Role of Urokinase Receptor in Chondrosarcoma Cell Movement
Author Information
Author(s): Katia Bifulco, Immacolata Longanesi-Cattani, Maria Teresa Masucci, Annarosaria De Chiara, Flavio Fazioli, Gioconda Di Carluccio, Giuseppe Pirozzi, Michele Gallo, Antonello La Rocca, Gaetano Apice, Gaetano Rocco, Maria Vincenza Carriero
Primary Institution: National Cancer Institute of Naples
Hypothesis
High levels of soluble urokinase receptor (SuPAR) in chondrosarcoma may promote cell migration and invasion.
Conclusion
The study found that SuPAR promotes chondrosarcoma cell migration and invasion, suggesting its potential as a therapeutic target.
Supporting Evidence
- High levels of uPAR and SuPAR correlate with poor prognosis in chondrosarcoma patients.
- Chondrosarcoma cells release a large amount of SuPAR into the medium.
- In vitro assays showed that SuPAR enhances cell migration and invasion.
Takeaway
Chondrosarcoma cells can move and invade tissues better when they have more SuPAR, which is a protein that helps them do this.
Methodology
The study involved analyzing uPAR levels in tissues and plasma from patients, creating primary cell cultures, and conducting migration and invasion assays.
Limitations
The study had a small sample size and focused only on in vitro experiments.
Participant Demographics
Patients aged 34 to 72 years, with varying grades of chondrosarcoma.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website